Explore our company news, announcements and updates
September 9, 2025
MSD Animal Health Launches NUMELVI® (atinvicitinib) Tablets for Dogs – A Veterinary Innovation in Fast, Effective and Safe Targeted Itch Relief
August 19, 2025
Vets and Pet-Owners See Gaps in Flea and Tick Prevention, Highlighting Need for Year-Round Care, New MSD Animal Health Global Survey Finds
August 18, 2025
MSD Animal Health Presents New Data Highlighting Commitment to the Development and Study of Parasite Prevention and Treatment for Dogs at the 2025 World Association for the Advancement of Veterinary Parasitology Congress
July 10, 2025
FDA Approves BRAVECTO® QUANTUM (Fluralaner for Extended-Release Injectable Suspension) from MSD Animal Health
June 12, 2025
MSD Animal Health Receives Positive Opinion from CVMP for NOBIVAC® L6 and NOBIVAC® LoVo L6 Vaccines for Use in Dogs Against Leptospirosis
June 12, 2025
MSD Animal Health Receives EU CVMP Positive Opinion for NUMELVI™ (atinvicitinib) Tablets for Dogs
May 16, 2025
MSD Animal Health Receives Positive CVMP Opinion for INNOVAX®-ND-IBD-ILT for Use in Chickens
May 12, 2025
MSD Animal Health Demonstrates its Commitment to Ruminant Health at the 2025 European Buiatrics Congress
May 2, 2025
FDA Approves MSD Animal Health’s MOMETAMAX SINGLE™ to Treat Otitis Externa in Dogs
March 27, 2025
MSD Animal Health Announces the European Approval of NOBILIS MULTRIVA™ REOm for Use in Chickens
February 24, 2025